Ironwood is advancing apraglutide, a next-generation, synthetic glucagon-like peptide-2 (“GLP-2”) analog for short bowel syndrome (“SBS”) patients dependent on parenteral support (“PS”), a severe ...

Developer Ironwood Studios' debut release sold one million units, and considering that around 35 people worked on it during the peak of development, that's quite the upsell on the reasonably ...

We independently select these products—if you buy from one of our links, we may earn a commission. All prices were accurate at the time of publishing. Dark wood has always ebbed and flowed in ...